Quantitative Sensory Testing to Study Pain Perception in Autism (PPiA)

October 24, 2024 updated by: IRCCS Eugenio Medea

Pain Perception in Autism. Study Through Quantitative Sensory Testing and Psychophysiological Correlates

This study aims at assess sensory perception, and pain perception, in neurodivergent children and adolescent in the autism spectrum. To achieve this goal, the quantitive sensory testing (QST), a controlled and replicable protocol, will be used, to assess perception in different sensory modalities: heat sensations, mechanical detection threshold and pain threshold. As secondary aim, the cortical processing of thermal painful stimuli will be collected through electroencephalography (EEG) in order to investigate if there are differences in the cortical processing of painful stimuli between clinical sample and control sample, and if it could be associated with differences in the subjective experience between the two groups. Finally, it will be explored the association between such differences, and indexes of psychopathology and dispositional measures.

Study Overview

Detailed Description

Study procedure imply the following steps: 1. Eligibility assessment according to inclusion and exclusion criteria. 2. Administration of questionnaires and scales for the characterization of clinical aspects of autism: Short sensory profile; The Autism Spectrum Quotient: Children's Version; Vineland Adaptive Behaviour Scales-Second Edition. The Vineland Adaptive Behaviour Scales-Second Edition; The Child Behavior Checklist (CBCL). 3. Administration of Quantitative Sensory Testing to study sensory thresholds and perception. 4. EEG recording at rest as well as while receiving heat stimuli to study cortical processing of salient thermal stimuli.

The QST protocol, implies the administration of 7 short sensory test in order to measure up to 13 parameters, which can be grouped as follows: thermal detection thresholds for the perception of cold, warm and paradoxical heat sensations, thermal pain thresholds for cold and hot stimuli, mechanical detection thresholds for touch and vibration, mechanical pain thresholds and sensitivity for pinprick and blunt pressure, vibration detection threshold and pressure pain threshold. Previous research with QST in neurodevelopmental disorders used modified version of the whole protocol, to make it suitable and tolerable for different clinical condition such as developmental delay including motor, communicative, and cognitive impairments. Thus, we will also administer the most suitable and tolerable version of the QST according to each patient condition and needs, for example we plan to reduce the number of stimuli for each stimulation side when needed, in order to reduce stimulus trial duration as well. The whole procedure will be implemented in a kids friendly environment, colourful and comfortable, and sensory stimuli will be adapted in order to avoid fearfulness of the stimuli, thus each stimulation will be presented as a game to be played with a specific animal, and each device and instrument will be covered with animals pictures according to the game it represents. Overall QST last about 1h 30 minutes, it will be divided in at least two sessions according to patients' needs.

The EEG recording consist in the cap montage at first, then a short accommodation with the sensory stimuli in order to find an intensity value for a moderate painful stimulus, to be used for the stimulation. After the preparation/accommodation, the eeg recording will start while a series, up to 30 thermal stimuli, will be delivered to the patients' hand dorsum. The whole eeg recording last about 30 minutes and it will be implemented in one session only.

Study Type

Observational

Enrollment (Estimated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • BR
      • Brindisi, BR, Italy, 72100

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Children and adolescent between 5 and 17 years old

Description

Inclusion Criteria for the clinical sample:

  • Children and adolescent
  • age between 5 and 17 years old
  • Autism diagnosis according to DSM-V criteria

Inclusion Criteria for the control sample:

  • healthy children and adolescent (without neurological, and psychiatric, diagnoses)
  • age between 5 and 17 years old

Exclusion Criteria:

Comorbidities with (for the clinical sample) or diagnosis of (for the control sample):

  • peripheral neuropaties;
  • psychiatric diagnosis as psychosis,
  • Tourette Syndrome,
  • neurological diagnoses as epilepsy,
  • sensory deficit or loss;
  • genetic diseases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
ASD Group
Patients with ASD diagnosis according to DSM-V, between 5 and 17 years old
The QST protocol (Rolke et al., 2006; Blankenburg et al., 2010), implies the administration of 7 short sensory test in order to measure up to 13 parameters, which can be grouped as follows: thermal detection thresholds for the perception of cold, warm and paradoxical heat sensations, thermal pain thresholds for cold and hot stimuli, mechanical detection thresholds for touch and vibration, mechanical pain thresholds and sensitivity for pinprick and blunt pressure, vibration detection threshold and pressure pain threshold.
EEG recording at rest and while receiving heat stimuli to study cortical processing of salient thermal stimuli. Up to 30 painful thermal stimuli, will be delivered to the patients' hand dorsum in order to register contact heat evoked potentials (CHEPs).
Control Group
Healthy participants, between 5 and 17 years old, without ASD diagnosis and withour neurological and psychiatric deseases
The QST protocol (Rolke et al., 2006; Blankenburg et al., 2010), implies the administration of 7 short sensory test in order to measure up to 13 parameters, which can be grouped as follows: thermal detection thresholds for the perception of cold, warm and paradoxical heat sensations, thermal pain thresholds for cold and hot stimuli, mechanical detection thresholds for touch and vibration, mechanical pain thresholds and sensitivity for pinprick and blunt pressure, vibration detection threshold and pressure pain threshold.
EEG recording at rest and while receiving heat stimuli to study cortical processing of salient thermal stimuli. Up to 30 painful thermal stimuli, will be delivered to the patients' hand dorsum in order to register contact heat evoked potentials (CHEPs).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
EEG responses in the time domain
Time Frame: from the enrollment to the end of EEG recordin (approx. 3 days)
ERPs amplitude (μV)
from the enrollment to the end of EEG recordin (approx. 3 days)
Cold detection threshold
Time Frame: from the enrollment to the end of QST administration (approx. 2 days)
The minimum intensity value (°C) at which a cold stimulus is perceived by each participant
from the enrollment to the end of QST administration (approx. 2 days)
Warm detection threshold
Time Frame: from the enrollment to the end of QST administration (approx. 2 days)
The minimum intensity value (°C) at which a warm stimulus is perceived by each participant
from the enrollment to the end of QST administration (approx. 2 days)
Cold pain threshold
Time Frame: from the enrollment to the end of QST administration (approx. 2 days)
The minimum intensity value (°C) at which a cold stimulus is perceived as painful by each participant
from the enrollment to the end of QST administration (approx. 2 days)
Warm pain threshold
Time Frame: from the enrollment to the end of QST administration (approx. 2 days)
The minimum intensity value (°C) at which a warm stimulus is perceived as painful by each participant
from the enrollment to the end of QST administration (approx. 2 days)
Mechanical detection threshold
Time Frame: from the enrollment to the end of QST administration (approx. 2 days)
The minimum intensity value (mN) at which a mechanical stimulus is perceived by each participant. It is a measure of touch perception
from the enrollment to the end of QST administration (approx. 2 days)
Mechanical pain threshold
Time Frame: from the enrollment to the end of QST administration (approx. 2 days)
The minimum intensity value (mN) at which a mechanical stimulus is perceived as painful by each participant.
from the enrollment to the end of QST administration (approx. 2 days)
Vibration detection threshold
Time Frame: from the enrollment to the end of QST administration (approx. 2 days)
The minimum intensity value (Hz) at which a vibratory stimulus is perceived by each participant.
from the enrollment to the end of QST administration (approx. 2 days)
Pressure pain threshold
Time Frame: from the enrollment to the end of QST administration (approx. 2 days)
The minimum intensity value (N) at which a pressure stimulus is perceived as painful by each participant.
from the enrollment to the end of QST administration (approx. 2 days)
EEG responses in the time-frequency domain
Time Frame: from the enrollment to the end of QST administration (approx. 3 days)
Power-spectrum of eeg responses
from the enrollment to the end of QST administration (approx. 3 days)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 17, 2024

Primary Completion (Estimated)

July 1, 2025

Study Completion (Estimated)

September 1, 2025

Study Registration Dates

First Submitted

October 14, 2024

First Submitted That Met QC Criteria

October 24, 2024

First Posted (Actual)

October 26, 2024

Study Record Updates

Last Update Posted (Actual)

October 26, 2024

Last Update Submitted That Met QC Criteria

October 24, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe